September 22, 2021

Volume XI, Number 265

Advertisement

September 21, 2021

Subscribe to Latest Legal News and Analysis

September 20, 2021

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Date Title Organization
1
Jun
FDA Adds Four New Substances to its Inventory of Effective FCS Notifications 2021 Keller and Heckman LLP
1
Jun
DOE Argonne National Laboratory Publishes Retrospective Analysis Of Changes In U.S. Corn Ethanol GHG Emission Intensity Throughout The Years Bergeson & Campbell, P.C.
1
Jun
EC implementation guidelines on the Single-Use Plastics (SUP) directive are finally there…! Keller and Heckman LLP
29
May
EEOC Updates COVID-19 Guidance Regarding Vaccination Incentives, Reasonable Accommodation, and Other Issues Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
28
May
CBD Here, CBD There, CBD Everywhere: Tension Between State and Federal Authorities Leaves CBD Companies in Limbo Strassburger McKenna Gutnick & Gefsky
28
May
Controversy over Online Country of Origin Labeling Keller and Heckman LLP
28
May
CFTC Announces Agricultural Advisory Committee Meeting Katten
28
May
TSCA Section 4 and Consortia Formation — A Conversation with Heather Blankinship and Richard Engler, Ph.D. [PODCAST] Bergeson & Campbell, P.C.
27
May
Florida Supreme Court Declares Medical Marijuana Statute’s Vertical Integration Requirement Constitutional and Confirms Caps on Licensees Greenberg Traurig, LLP
27
May
Washington State Seeks Input for 2nd PFAS in Food Packaging Alternative Assessment Keller and Heckman LLP
27
May
Sovereign Wealth Fund Investment in the Global Healthcare Industry McDermott Will & Emery
27
May
Pharmaceutical and Medical Device Manufacturers Be Advised: Sunshine Act / Open Payments Enforcement is on the Rise Mintz
27
May
FDA Warns Companies over Unapproved Fertility Claims Keller and Heckman LLP
27
May
FMCSA Issues Reminder To CDL Drivers Regarding Use Of CBD Products Jackson Lewis P.C.
27
May
DOE Announces Investment In R&D For Plastic Recycling Technologies Bergeson & Campbell, P.C.
26
May
340B Update: HRSA Issues Final Warning Letter to Pharmaceutical Manufacturers that Their Contract Pharmacy Actions Violate 340B Statute K&L Gates
26
May
Agricultural Exemption Does Not Apply to Activities Entirely Away from the Farm Jackson Lewis P.C.
26
May
China’s President Xi Jinping Throws His Support Behind an Intellectual Property Rights Waiver for COVID Vaccines Schwegman, Lundberg & Woessner, P.A.
26
May
FDA Publishes FY20-FY21 Romaine Lettuce Sampling Results Keller and Heckman LLP
25
May
Brain Interfaces Bring Us Closer to a Life of the Mind Womble Bond Dickinson (US) LLP

Pages

Advertisement
Advertisement